Trading Signals: VNDA Stock Price Prediction and Forecast (Wed. Apr. 12, 2006 - Fri. May. 26, 2023)(Vanda Pharmaceuticals Inc.)
| VNDA latest price $13.4300 (-3.8%) ($13.3300 - $13.9300) on Thu. Jul. 11, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.04% (three month average) | | RSI | 41 | | Latest Price | $13.4300(-3.8%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | VNDA declines -0.9% a day on average for past five trading days. | | Weekly Trend | VNDA declines -1.1% a week on average for past two weeks. | | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support VNDA advance at 0% a week (0% probability)
XBI(48%) IBB(41%) IWO(40%) IWC(39%) IWM(39%) | | Factors Impacting VNDA price | VNDA will decline at least -1.52% in a week (0% probabilities).
VIXM(-31%) VXX(-14%) TLT(-11%) IFRA(-7%) IGOV(-4%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.52% (StdDev 3.04%) | | Hourly BBV | 0 () | | Intraday Trend | -3.6% | | | | | |
|
| Resistance Level | $14.09 | | 5 Day Moving Average | $13.7(-1.97%) | | 10 Day Moving Average | $13.85(-3.03%) | | 20 Day Moving Average | $14.09(-4.68%) | | To recent high | -24% | | To recent low | 0.4% | | Market Cap | $734m | | | | | | |
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC. |